In our study, treating STZ-induced diabetic mice with an AT1 receptor blocker attenuated diabetes-induced cardiac hypertrophy and fibrosis, indicating that diabetes-induced cardiac hypertrophy and fibrosis signaling is mediated through the AT1 receptor. This evidence concerns the gene AGTR1 and cardiac hypertrophy.